Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 3, 2004, Pages 167-173

  Marinelli, Lieta ^a   Gabai, Gianfranco ^a   Wolfswinkel, Jeannette ^b   Mol, Jan A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Dog; Hyperplasia; Mammary gland; Progestins; Steroid metabolism; Tumorigenesis

Indexed keywords

AROMATASE; ESTRADIOL; OXIDOREDUCTASE; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CONTROLLED STUDY; DOG; FEMALE; HYPERPLASIA; MAMMARY GLAND; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CANIS FAMILIARIS;

EID: 8844267669     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.08.001     Document Type: Article

References (59)

1. W. Song, and M.-H. Melner Editorial: steroid transformation enzymes as a critical regulators of steroid action in vivo Endocrinology 141 2000 1587 1589
2. M. Peaker Production of hormones by the mammary gland: short review Endocr. Regul. 25 1991 10 13
3. C.-A. Slotin, R.-B. Heap, J.-M. Christiansen, and J.-L. Linzell Synthesis of progesterone by the mammary gland of the goat Nature 225 1970 385 386
4. E. Perel, and D.-W. Killinger The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue J. Steroid Biochem. Mol. Biol. 19 1983 1135 1139
5. W.-R. Miller Aromatase activity in breast tissue J. Steroid Biochem. Mol. Biol. 39 1991 783 790
6. P. Belvedere, G. Gabai, L. Dalla Valle, P. Accorsi, M. Trivoletti, L. Colombo, and G. Bono Occurrence of steroidogenic enzymes in the bovine mammary gland at different functional stages J. Steroid Biochem. Mol. Biol. 59 1996 339 347
7. C.-N. D'Arville, B.-A.-J. Evans, G. Borthwick, and C.-G. Pierrepoint Aspect of steroid metabolism in the normal and neoplastic mammary gland of the bitch J. Steroid Biochem. 13 1980 1407 1411
8. R.-V. Lloyd Studies on the progesterone receptor content and steroid metabolism in normal and pathological human breast tissues J. Clin. Endocrinol. Metab. 48 1979 585 593
9. M. Mori, T. Tomnaga, and B. Tamaoki Steroid metabolism in the normal mammary gland and in dimethylbenzanthracene-induced mammary tumor of rats Endocrinology 102 1978 1387 1397
10. W.-R. Miller Pathways of hormone metabolism in normal and nonneoplastic breast tissue Ann. N.Y. Acad. Sci. 586 1990 53 59
11. N.-J. Kenney, and R.-B. Dickson Growth factor and sex steroid interaction in breast cancer J. Mammary Gland Biol. Neoplasia 1 2 1996 189 198
12. R.-B. Dickson, and M.-E. Lippman Growth factors in breast cancer Endocr. Rev. 16 5 1995 559 589
13. W.-R. Miller, R.-A. Hawkins, and A.-P. Forrest Significance of aromatase activity in human breast cancer Cancer Res. 42 Suppl 1982 3365s 3368s
14. E. Perel, D. Wilkins, and D.-W. Killinger The conversion of androstenedione to estrone, estradiol and testosterone in breast tissue J. Steroid Biochem. 13 1980 89 94
15. W. Yue, J.-P. Wang, C.-J. Hamilton, L.-M. Demers, and R.-J. Santen In situ aromatization enhances breast tumor estradiol levels and cellular proliferation Cancer Res. 58 1998 927 932
16. M.-C. Silva, M.-G. Rowlands, M. Downsett, B. Gusterson, J.-A. McKinna, I. Fryatt, and R.-C. Coombes Intratumoral aromatase as a prognostic factor in human breast carcinoma Cancer Res. 49 1989 2588 2591
17. W.-R. Miller, T.-J. Anderson, and W.-J. Jack Relationship between tumor aromatase activity, tumor characteristic and response to therapy J. Steroid Biochem. Mol. Biol. 1990 37
18. S.-E. Bulun, T.-M. Price, J. Aitken, M.-S. Mahendroo, and E.-R. Simpson A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription J. Clin. Endocrinol. Metab. 77 1993 1622 1628
19. H. Sasano, and M. Ozaki Aromatase expression and its localization in human breast cancer J. Steroid Biochem. Mol. Biol. 61 3-6 1997 293 298
20. M. Dowsett Endocrine treatment of advanced breast cancer Acta Oncol. 35 Suppl 1996 68 72
21. A.-M.-H. Brodie, and V.-C.-O. Njar Aromatase inhibitors and their application in breast cancer treatment Steroids 2000 171 179
22. R.-W. Nelson, and C.-G. Couto Disorders of the mammary gland Essential of Small Animals Internal Medicine 1992 Mosby Year Book Inc. St. Louis
23. R. Schneider, C.-R. Dorn, and D.-O.-N. Taylor Factor influencing canine mammary cancer development and post-surgical survival J. Natl. Cancer Inst. 43 1969 1249 1261
24. R. Schneider Comparison of age, sex and incidence rate in human and canine breast cancer Cancer 1970 419 426
25. W. Misdorp Canine mammary tumours: protective effect of late ovariectomy and stimulating effects of progestin Vet. Q. 10 1988 26 33
26. B.-S. Hulka, and A.-T. Stark Breast cancer: cause and prevention Lancet 346 1995 883 887
27. W. Misdorp Progestagens and mammary tumours in dogs and cats Acta Endocricol. 125 1991 27 31
28. G.-R. Rutteman Contraceptive steroids and the mammary gland: is there a hazard? Insights from animal studies Breast Cancer Res. Treat. 23 1992 29 41
29. J.-A. Mol, E. van Garderen, G.-R. Rutteman, and A. Rijnberk New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans J. Steroid Biochem. Mol. Biol. 57 1996 61 67
30. P.-W. Concannon, T.-R. Spraker, H.-W. Casey, and W. Hansel Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult female beagle bitches Fertil. Steril. 36 1981 373 387
31. J.-P. Wiebe, D. Munzia, J. Hu, D. Szwajcer, S.-A. Hill, and J.-L. Seachrist The 4-pregnene and 5α-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects an breast cell proliferation and adhesion Cancer Res. 60 2000 936 943
32. 4-3-keto-steroid 5α-oxidoreductase of rat prostate J. Biol. Chem. 246 1971 2584 2593
33. E. Perel, D. Daniilescu, L. Kharlip, M.-E. Blackstein, and D.-W. Killinger The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture Mol. Cell. Endocrinol. 41 1985 197 203
34. P.-J. Selman, J.-A. Mol, G.-R. Rutteman, and A. Rijnberk Progestin-induced growth hormone excess in the dog originates in the mammary gland Endocrinology 134 1994 287 292
35. J.-F. Hampe, and W. Misdorp Tumours and dysplasias of the mammary gland Bulletin (W.H.O.) 50 1979 111 113
36. R.-E. Farrel Jr. RNA isolation strategies RNA methodologies. A Laboratory Guide for Isolation and Characterization 1993 Academic Press Limited London pp. 76-82
37. G.-R. Rutteman, and W. Misdorp Steroid receptor determinations in malignant mammary tumors and in nonaffected mammary glands in the dog Ann. N.Y. Acad. Sci. 464 1986 468
38. G. Scatchard The attractions of proteins for small ions and molecules Ann. N.Y. Acad. Sci. 51 1949 660
39. P.-J. Munson, and D. Rodbard Ligand: a versatile computerized approach for the characterization of ligand binding systems Anal. Biochem. 107 1980 178 180
40. R.-L. Sutherland, O.-W. Prall, C.-K. Watts, and E.-A. Musgrove Estrogen and progestin regulation of cell cycle progression J. Mammary Gland Biol. Neoplasia 3 1998 63 72
41. C.-A. Lange, J.-K. Richer, and K.-B. Horwitz Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals Mol. Endocrinol. 13 1999 829 836
42. S.-N. Birrell, R.-E. Hall, and W.-D. Tilley Role of the androgen receptor in human breast cancer J. Mammary Gland Biol. Neoplasia 3 1998 95 103
43. J.-M. Bentel, S.-N. Birrell, M.-A. Pickering, D.-J. Holds, D.-J. Horsfall, and W.-D. Tilley Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells Mol. Cell Endocrinol. 154 1999 11 20
44. P.-H.-B. Willemse, L.-D. Dikkeschei, T. Tjabbes, H. Vanveelen, and D.-T. Sleijfer Adrenal steroids as parameters of the bioavailability of MA and MPA Eur. J. Cancer. 26 1990 359 362
45. H. Vanveelen, P.-H.-B. Willemse, D.-T. Sleijfer, W.-J. Sluiter, and H. Doorenbos Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer Cancer Treat. Rep. 69 1985 977 983
46. G.-R. Rutteman, R. Stolp, A. Rijnberk, S. Loeffler, J.-A. Bakker, M.-M. Bevers, P.-M. Meulenberg, and J.-E. Eigenmann Medroxyprogesterone acetate administration to ovariohiysterectomized oestradiol-primed beagle bitches Acta Endocrinol. 114 1987 275 282
47. J.-P. McCann, N. Altszuler, J. Hampshire, and P.-W. Concannon Growth hormone, insuline, glucose, cortisol, luteinizing hormone and diabetes in beagle bitches treated with medroxyprogesterone acetate Acta Endocrinol. 116 1987 73 80
48. P.-J. Selman, J.-A. Mol, G.-R. Rutteman, and A. Rijnberk Progestin treatment in the dogs: effect on the hypothalamic-pituitary-adrenal axis Eur. J. Endocrinol. 131 1994 422 430
49. C.-B. Chastain, C.-L. Graham, and C.-E. Nichols Adrenocortical suppression in cats given megestrol acetate Am. J. Vet. Res. 51 1981 60 65
50. D.-J. Middleton, A.-D.-J. Watson, and I.-D. Caterson Suppression of cortisol responses to exogenous adrenocorticotrophic hormone and the occurrence of side effects attributable to glucocorticoid excess, in cats during therapy with megestrol acetate and prednisolone Can. J. Vet. Res. 51 1987 60 65
51. S. Lundgren, P.-E. Lonning, E. Utaaker, A. Aakvaag, and S. Kvinnsland Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer. I. General finding J. Steroid Biochem. 36 1-2 1990 99 104
52. M. Dowsett, A. Lal, I.-E. Smith, and S.-L. Jeffcoate The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients Br. J. Cancer 55 3 1987 311 313
53. S. Lundgren, S.-I. Helle, and P.-E. Lonnig Profound suppression of plasma etrogens by megestrol acetate in postmenopausal breast cancer patients Clin. Cancers Res. 9 1996 1515 1521
54. G. Pridjian, V. Schmit, and J. Schreiber Medroxypogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells J. Steroid Biochem. 26 3 1987 313 319
55. J.-R. Schreiber, K. Nakamura, and G.-F. Erickson Progestins inhibit FSH-stimulated steroidogenesis in cultured rat granulosa cells Mol. Cell Endocrinol. 19 2 1980 165 173
56. J.-R. Pasqualini, J. Paris, R. Sitruk-Ware, G. Chetrite, and J. Botella Progestins and breast cancer J. Steroid Biochem. Mol. Biol. 65 1998 225 235
57. P.-J. Weiler, and J.-P. Wiebe Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5a-pregnane-3,20-dione and 3a-hydroxy-4-pregen-20-one in MCF-7 breast cancer cells Biochem. Biophys. Res. Commun. 272 2000 731 737
58. H. Sasano, and N. Harada Intratumoral aromatase in human breast, endometrial, and ovarian malignancies Endocr. Rev. 19 1998 593 607
59. D.-R. Ciocca, and M.-A. Fanelli Estrogen receptors and cell proliferation in breast cancer Trends Endocrinol. Metab. 8 1997 312 313